Ligand Pharmaceuticals Notes Receivable (Quarterly) Analysis

Ligand Pharmaceuticals, Inc. (LGND)

194.94 -0.88 (-0.45%) USD | NASDAQ | Dec 29, 16:00

194.94 0.00 (0.00%) After-Hours: 20:00

Notes Receivable (Quarterly) Chart

View Notes Receivable (Quarterly) for LGND.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Notes Receivable (Quarterly) Chart

Start Trial

Historical Data

View Historical Data

Start Trial

Notes Receivable Definition

View Notes Receivable Definition

Start Trial

Notes Receivable represents written obligations the creditors receive from the debtors in exchange for funds. Notes Receivable is part of a company’s assets.

Read full definition.

Notes Receivable (Quarterly) Range, Past 5 Years

View Notes Receivable (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Notes Receivable (Quarterly) Benchmarks

View Notes Receivable (Quarterly) Benchmarks

Start Trial

Merck & Co., Inc.	--
Johnson & Johnson	--
Inspire Medical Systems, Inc.	--
Elanco Animal Health, Inc.	--
Alnylam Pharmaceuticals, Inc.	--